UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ultraviolet phototherapy for cutaneous diseases: a concise review

Oral diseases, 2016-05, Vol.22 (4), p.253-259

2016

Volltextzugriff (PDF)

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

British journal of dermatology (1951), 2015-10, Vol.173 (4), p.949-961

2015

Volltextzugriff (PDF)

The genetics of pyoderma gangrenosum and implications for treatment: a systematic review

British journal of dermatology (1951), 2015-06, Vol.172 (6), p.1487-1497

2015

Volltextzugriff (PDF)

Evidence is lacking for or against palmoplantar pustulosis treatments: what does this mean for the clinician

British journal of dermatology (1951), 2021-06, Vol.184 (6), p.990-990

2021

Volltextzugriff (PDF)

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents

Journal of the American Academy of Dermatology, 2014-08, Vol.71 (2), p.327

2014

Volltextzugriff (PDF)

Biologics are too complicated to duplicate: should we be worried about biosimilars?

British journal of dermatology (1951), 2018-09, Vol.179 (3), p.557-558

2018

Volltextzugriff (PDF)

A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial

British journal of dermatology (1951), 2018-11, Vol.179 (5), p.1062-1071

2018

Volltextzugriff (PDF)

Overcoming poor adherence is a major hurdle to managing atopic dermatitis

British journal of dermatology (1951), 2020-04, Vol.182 (4), p.836-837

2020

Volltextzugriff (PDF)

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Journal of the American Academy of Dermatology, 2016-05, Vol.74 (5), p.841-850

2016

Volltextzugriff (PDF)

A hands‐off approach may be more successful in treating chronic hand eczema

British journal of dermatology (1951), 2020-05, Vol.182 (5), p.1078-1078

2020

Volltextzugriff (PDF)

A changed life: the life experiences of patients with psoriasis receiving biological treatment

British journal of dermatology (1951), 2020-09, Vol.183 (3), p.516-523

2020

Volltextzugriff (PDF)

The perceived promise of p19 inhibitors

British journal of dermatology (1951), 2018-09, Vol.179 (3), p.556-557

2018

Volltextzugriff (PDF)

Tildrakizumab: interpreting the data

British journal of dermatology (1951), 2021-08, Vol.185 (2), p.242-243

2021

Volltextzugriff (PDF)

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

Journal of the American Academy of Dermatology, 2008-05, Vol.58 (5), p.826-850

2008

Volltextzugriff (PDF)

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions

Journal of the American Academy of Dermatology, 2011-07, Vol.65 (1), p.137-174

2011

Volltextzugriff (PDF)

Lead with your gut: research‐implicated infant gut staphylococcal strains may predict development of atopic dermatitis

British journal of dermatology (1951), 2019-06, Vol.180 (6), p.1296-1297

2019

Volltextzugriff (PDF)

Long‐term adherence to topical psoriasis treatment can be abysmal: a 1‐year randomized intervention study using objective electronic adherence monitoring

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.759-764

2017

Volltextzugriff (PDF)

Dermatology Life Quality Index: does improving the instrument make it better?

British journal of dermatology (1951), 2020-05, Vol.182 (5), p.1082-1083

2020

Volltextzugriff (PDF)

Participating in trials can inform better clinical practice

British journal of dermatology (1951), 2017-11, Vol.177 (5), p.1148-1149

Feldman, S.R.

2017

Volltextzugriff (PDF)

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies

Journal of the American Academy of Dermatology, 2009-04, Vol.60 (4), p.643-659

2009

Volltextzugriff (PDF)

Yet another step forward

British journal of dermatology (1951), 2018-01, Vol.178 (1), p.22-22

Feldman, S.R.

2018

Volltextzugriff (PDF)

Barriers to treatment: describing them from a different perspective

Patient preference and adherence, 2018-01, Vol.12, p.129-133

2018

Volltextzugriff (PDF)

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review

Patient preference and adherence, 2018-01, Vol.12, p.1483-1503

2018

Volltextzugriff (PDF)

Long‐term efficacy of certolizumab pegol for psoriasis

British journal of dermatology (1951), 2021-04, Vol.184 (4), p.588-589

2021

Volltextzugriff (PDF)

Comparison of injection‐site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study

British journal of dermatology (1951), 2018-03, Vol.178 (3), p.e215-e216

2018

Volltextzugriff (PDF)

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(233)

Publikationsform

Sprache

Englisch
(250)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ultraviolet phototherapy for cutaneous diseases: a concise review

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

The genetics of pyoderma gangrenosum and implications for treatment: a systematic review

Evidence is lacking for or against palmoplantar pustulosis treatments: what does this mean for the clinician

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents

Biologics are too complicated to duplicate: should we be worried about biosimilars?

A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial

Overcoming poor adherence is a major hurdle to managing atopic dermatitis

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

A hands‐off approach may be more successful in treating chronic hand eczema

A changed life: the life experiences of patients with psoriasis receiving biological treatment

The perceived promise of p19 inhibitors

Tildrakizumab: interpreting the data

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions

Lead with your gut: research‐implicated infant gut staphylococcal strains may predict development of atopic dermatitis

Long‐term adherence to topical psoriasis treatment can be abysmal: a 1‐year randomized intervention study using objective electronic adherence monitoring

Dermatology Life Quality Index: does improving the instrument make it better?

Participating in trials can inform better clinical practice

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies

Yet another step forward

Barriers to treatment: describing them from a different perspective

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review

Long‐term efficacy of certolizumab pegol for psoriasis

Comparison of injection‐site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study

Suchergebnisse filtern